Denemek ALTIN - Özgür

Apple's restraint in AI spending becomes a plus

Los Angeles Times

|

November 12, 2025

Its rivals are coming under scrutiny as they invest large sums into the technology.

- BY RYAN VLASTELICA AND CARMEN REINICKE

Apple's restraint in AI spending becomes a plus

APPLE IPHONE 17 models are on display in September at a company event on its campus in Cupertino, Calif.

(Nic Coury AFP/Getty Images)

Apple Inc. has faced plenty of criticism from Wall Street for not spending as aggressively on artificial intelligence as its Big Tech rivals. But that strategy is suddenly a blessing for the iPhone maker.

Investors are beginning to scrutinize the huge sums companies such as OpenAI, Meta Platforms Inc. and Microsoft Corp. are spending on AI, leading to heavy volatility in what had been some of the year’s biggest momentum plays. As a result, Apple’s position is being reevaluated.

Although it’s still considered a potential AI winner, the company doesn’t carry the risk of heavy capital expenditures and it does have ample cash on its books. That makes Apple shares a potential haven within the technology industry if the AI trade unwinds further.

The trend is playing out in early Tuesday trading, as Apple shares are up 0.8% and the leading point gainer in the Standard & Poor's 500 index, while AI darlings Nvidia Corp., Meta and Microsoft are dragging the market down.

“The hedge is it’s still a technology company, but not an AI company,” said Brian Mulberry, client portfolio manager at Zacks Investment Management. “There is this positive feel for Apple that they don’t have to answer the big question that everybody else does, which is: What is the return on your invested capital in all of these other areas?”

Los Angeles Times'den DAHA FAZLA HİKAYE

Los Angeles Times

Paramount sheds 1,600 more workers as Ellison's team digs in

Tech scion David Ellison marked his 96th day running Paramount by disclosing an upbeat financial outlook for next year and a plan to reduce an additional 1,600 workers.

time to read

3 mins

November 12, 2025

Los Angeles Times

Los Angeles Times

A facade at national parks?

Camps and bathrooms stayed open, but behind the scenes, conservation and research services ended during shutdown

time to read

5 mins

November 12, 2025

Los Angeles Times

Los Angeles Times

New visa rules may bar obese people

Medical conditions can be reason to reject overseas applicants, White House says.

time to read

3 mins

November 12, 2025

Los Angeles Times

Los Angeles Times

INSIDE THE SEARCH FOR MELODEE

As details emerge in the missing girl's case, her relatives are frantic for answers

time to read

5 mins

November 12, 2025

Los Angeles Times

Los Angeles Times

McIlroy's legacy is secure, but he's not ready to lay up

Desire to win drives Masters winner, and he has goals, including perhaps ’28 Olympics.

time to read

4 mins

November 12, 2025

Los Angeles Times

Los Angeles Times

'THE HUNGER GAMES' TAKES CENTER STAGE

The play, which adapts the first novel and film, opens at a theater designed as an interactive arena to amplify its brutality

time to read

8 mins

November 12, 2025

Los Angeles Times

LAPD's spending irritates council

L.A.'s elected leaders took a dramatic step to cut police spending this year, chopping in half the number of officers that Mayor Karen Bass had been hoping to hire.

time to read

3 mins

November 12, 2025

Los Angeles Times

California could be hit with days of heavy rain

A fast-moving atmospheric river is heading toward California this week and could pack a punch, threatening periods of heavy rain and possible flooding and debris flows in recently burned areas.

time to read

5 mins

November 12, 2025

Los Angeles Times

Los Angeles Times

Harden’s triple-double just not enough

The reeling Clippers lose fifth in a row as Hawks pull away in the final five minutes.

time to read

1 mins

November 12, 2025

Los Angeles Times

Los Angeles Times

Novartis opens new manufacturing plant in Carlsbad

Swiss drugmaker Novartis opened a new 10,000-square-foot manufacturing facility in Carlsbad to make cancer drugs, as part of its promised $23-billion investment push to build out its domestic U.S. facilities over the next five years.

time to read

1 mins

November 12, 2025

Listen

Translate

Share

-
+

Change font size